As for the origin of AKI during COVID-19, many causal factors have been proposed, including hyper-coagulation, microangiopathy, rhabdomyolysis, endothelial activation, dysregulation of complement, and angiotensin-converting enzyme 2 (ACE2) pathway activation (9, 10). Here, ACE2 is linked to COVID-19.